TNFAIP8 Overexpression: Clinical Relevance to Esophageal Squamous Cell Carcinoma

被引:61
作者
Hadisaputri, Yuni Elsa [1 ]
Miyazaki, Tatsuya [1 ]
Suzuki, Shigemasa [1 ]
Yokobori, Takehiko [1 ]
Kobayashi, Tsutomu [1 ]
Tanaka, Naritaka [1 ]
Inose, Takanori [1 ]
Sohda, Makoto [1 ]
Kuwano, Hiroyuki [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Maebashi, Gunma 371, Japan
基金
日本学术振兴会;
关键词
DEATH EFFECTOR DOMAIN; EXPRESSION; SCC-S2; METASTASIS; GENE; IDENTIFICATION; TRANSCRIPTION;
D O I
10.1245/s10434-011-2097-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background. Tumor necrosis factor alpha-induced protein 8 (TNFAIP8) is a suppressor of TNF-alpha mediated apoptosis, and its expression is induced by NF-kappa B activation. TNFAIP8 expression is significantly increased in various cancer cell lines. A correlation between TNFAIP8 overexpression, cancer progression, and poor prognosis has been described in many reports of human solid cancers. Methods. To clarify the functional and clinical significance of the cancer progression-related gene, TNFAIP8, in esophageal squamous cell carcinoma (ESCC), we used immunohistochemistry to demonstrate TNFAIP8 expression in ESCC. Next, TNFAIP8 expression was depleted by using siRNA to examine the function of TNFAIP8 in the proliferation and apoptosis induction of ESCC cell lines. Results. We detected correlations between TNFAIP8 expression and TNM stage (P < 0.001), tumor depth (P = 0.002), lymph node metastasis (P = 0.013), distant metastasis (P = 0.001), lymphatic invasion (P < 0.001), and venous invasion (P < 0.001) among the clinicopathological characteristics of ESCC patients, and high TNFAIP8 expression was found in poor survival. TNFAIP8 depletion was significantly associated with apoptosis induction after cisplatin administration and reduced proliferation. Conclusions. Our results suggest that TNFAIP8 might be an effective therapeutic target for ESCC in the future.
引用
收藏
页码:S589 / S596
页数:8
相关论文
共 14 条
[1]
Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer [J].
Dong, Qian-Ze ;
Zhao, Yue ;
Liu, Yang ;
Wang, Yang ;
Zhang, Peng-Xin ;
Jiang, Gui-Yang ;
Dong, Xin-Jun ;
Cui, Quan-Ze ;
Wang, En-Hua .
CANCER SCIENCE, 2010, 101 (06) :1562-1569
[2]
Differential expression of drug resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia [J].
Eisele, L. ;
Klein-Hitpass, L. ;
Chatzimanolis, N. ;
Opalka, B. ;
Boes, T. ;
Seeber, S. ;
Moritz, T. ;
Flasshove, M. .
ACTA HAEMATOLOGICA, 2007, 117 (01) :8-15
[3]
Surgical treatment for esophageal cancer [J].
Kato, Hiroyuki ;
Fukuchi, Minoru ;
Miyazaki, Tatsuya ;
Nakajima, Masanobu ;
Tanaka, Naritaka ;
Inose, Takanori ;
Kimura, Hitoshi ;
Faried, Ahmad ;
Saito, Kana ;
Sohda, Makoto ;
Fukai, Yasuyuki ;
Masuda, Norihiro ;
Manda, Ryokuhei ;
Ojima, Hitoshi ;
Tsukada, Katsuhiko ;
Kuwano, Hiroyuki .
DIGESTIVE SURGERY, 2007, 24 (02) :88-95
[4]
Kirillova I, 1999, CELL GROWTH DIFFER, V10, P819
[5]
Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells [J].
Kumar, D ;
Gokhale, P ;
Broustas, C ;
Chakravarty, D ;
Ahmad, I ;
Kasid, U .
ONCOGENE, 2004, 23 (02) :612-616
[6]
Identification of a novel tumor necrosis factor-α-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein [J].
Kumar, D ;
Whiteside, TL ;
Kasid, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2973-2978
[7]
TNFAIP8: A New Effector for Galpha(i) Coupling to Reduce Cell Death and Induce Cell Transformation [J].
Laliberte, Benoit ;
Wilson, Ariel M. ;
Nafisi, Houman ;
Mao, Helen ;
Zhou, Yi Yuen ;
Daigle, Mireille ;
Albert, Paul R. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 225 (03) :865-874
[8]
Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: Implications in metastasis and/or radiation response [J].
Patel, S ;
Wang, FH ;
Whiteside, TL ;
Kasid, U .
ORAL ONCOLOGY, 1997, 33 (03) :197-203
[9]
Siegel RL, 2020, ANTI-CANCER DRUG, V70, P7, DOI [10.3322/caac.21590, DOI 10.1097/CAD.0000000000000617]
[10]
Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI) [J].
Su, WB ;
Chang, YH ;
Lin, WW ;
Hsieh, SL .
EXPERIMENTAL CELL RESEARCH, 2006, 312 (03) :266-277